| 172.16 0.3 (0.17%) | 04-09 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 203.15 | 1-year : | 237.28 |
| Resists | First : | 173.93 | Second : | 203.15 |
| Pivot price | 166.23 |
|||
| Supports | First : | 165.12 | Second : | 159.67 |
| MAs | MA(5) : | 170.15 |
MA(20) : | 166.14 |
| MA(100) : | 170.23 |
MA(250) : | 149.18 |
|
| MACD | MACD : | 0.1 |
Signal : | -1 |
| %K %D | K(14,3) : | 87.5 |
D(3) : | 80.8 |
| RSI | RSI(14): 57.8 |
|||
| 52-week | High : | 179.5 | Low : | 109.41 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ IBB ] has closed below upper band by 11.6%. Bollinger Bands are 49.1% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 0 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 172.92 - 173.75 | 173.75 - 174.5 |
| Low: | 168.3 - 169.28 | 169.28 - 170.17 |
| Close: | 170.56 - 172.16 | 172.16 - 173.61 |
The iShares Biotechnology ETF seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector.
Thu, 09 Apr 2026
iShares Biotechnology ETF (IBB) Stock Price, News, Quote & History - Yahoo! Finance Canada
Wed, 08 Apr 2026
Ocean Park Tactical Core Growth Fund 's iShares Biotechnology ETF(IBB) Holding History - GuruFocus
Tue, 07 Apr 2026
XBI vs. IBB: The Biotech ETF Showdown That Analysts Say Has a Clear Winner in 2026 - 24/7 Wall St.
Thu, 02 Apr 2026
Biotech Is Holding Steady In 2026 (NASDAQ:IBB) - Seeking Alpha
Tue, 31 Mar 2026
Biotech Stocks Are Up About 35% in the Past Year and Analysts Say the Biggest Gains Are Still Ahead - 24/7 Wall St.
Sat, 21 Mar 2026
DAFNA Capital Trims iShares Biotechnology ETF Within Broader Biotech Portfolio, According to Recent SEC Filing - The Motley Fool
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|